MT Newswires on MSN12h
Eli Lilly Plans 4 New US Manufacturing Sites With $27 Billion Investment
Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...
Eli Lilly shares climb for seven consecutive sessions
Eli Lilly (NYSE:LLY) shares soar, driven by strong growth in weight-loss drugs, major investments, and bullish analyst ratings.
Eli Lilly to boost U.S. manufacturing footprint amid Trump’s tariff threats
Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on ...
Truist Financial Keeps Their Buy Rating on Eli Lilly & Co (LLY)
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares ...
Eli Lilly pays $10m upfront for Organovo’s FXR agonist
Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...
Crypto Data Space Teknoloji ve Medya Anonim Åžirketi22h
Onvo Stock- Eli Lilly Boosts Organovo’s Value with FXR Program Buyout
Onvo Stock- Organovo's stock jumps 200% after Eli Lilly acquires its FXR program, including the promising IBD treatment ...
FierceBiotech22h
Eli Lilly buys Organovo's FXR program for $10M, sending biotech's stock skyrocketing 244%
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...